Chembio Announces Agreements to Develop Point-of-Care Diagnostic Tests for …
This technology is providing Chembio with a significant pipeline of business opportunities for the development and manufacture of new products. Headquartered in Medford, NY, Chembio is licensed by the U.S. Food and Drug Administration (FDA) as well as …
Read more on CNNMoney
Charles River Laboratories Announces Third-Quarter 2014 Results from …
Revenue growth was driven by the acquisition of Argenta and BioFocus, which was completed on April 1, 2014 and contributed 8.0% to third-quarter revenue, as well as double-digit growth in the Manufacturing Support segment. ….. contaminations …
Read more on MarketWatch
The secret ingredient is time
This technology is providing Chembio with a significant pipeline of business opportunities for the development and manufacture of new products. Headquartered in Medford, NY, Chembio is licensed by the U.S. Food and Drug Administration (FDA) as well as …
Read more on Nasdaq
Leave a Reply